R-Biopharm Overview
- Year Founded
-
1988
- Status
-
Private
- Employees
-
1,400
- Latest Deal Type
-
2ndary - Private
- Financing Rounds
-
5
- Investments
-
13
R-Biopharm General Information
Description
Provider of diagnostic technologies and products designed intended for nutrition care and food analysis. The company provides quality control, analytical service, clinical diagnostics, and beer analysis, therefore enabling it to improve everyday life for many people and contribute to health.
Contact Information
Website
www.r-biopharm.comCorporate Office
- An der neuen Bergstraße 17
- 64297 Darmstadt
- Germany
Corporate Office
- An der neuen Bergstraße 17
- 64297 Darmstadt
- Germany
R-Biopharm Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
R-Biopharm Comparisons
Industry
Financing
Details
R-Biopharm Competitors (17)
One of R-Biopharm’s 17 competitors is VMRD, a Corporation company based in Pullman, WA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| VMRD | Corporation | Pullman, WA | ||||
| Astra Biotech | Corporation | Mountain View, CA | ||||
| Enzo Biochem | Private Equity-Backed | Farmingdale, NY | ||||
| Organogenesis Holdings | Pending Transaction (M&A) | Canton, MA | ||||
| Meridian Bioscience | Private Equity-Backed | Cincinnati, OH |
R-Biopharm Patents
R-Biopharm Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3524983-A1 | Method for quantification of total gluten from cereals in food samples | Inactive | 08-Feb-2018 | ||
| AU-2019218334-A1 | Method for the quantification of the total gluten content of grains in food samples | Active | 08-Feb-2018 | ||
| AU-2019218334-B2 | Method for the quantification of the total gluten content of grains in food samples | Active | 08-Feb-2018 | ||
| EP-3749955-A1 | Method for the quantification of the total gluten content of grains in food samples | Pending | 08-Feb-2018 | ||
| US-20200400638-A1 | Method for the quantification of the total gluten content of grains in food samples | Pending | 08-Feb-2018 | G01N33/02 |
R-Biopharm Signals
R-Biopharm Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
R-Biopharm Investments & Acquisitions (13)
R-Biopharm’s most recent deal was a Buyout/LBO with AusDiagnostics. The deal was made on 07-Jun-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| AusDiagnostics | 07-Jun-2022 | Buyout/LBO | Diagnostic Equipment | ||
| GeneWake | 29-Oct-2015 | Buyout/LBO | Biotechnology | ||
| PROGEN Biotechnik | 08-Oct-2012 | Buyout/LBO | Biotechnology | ||
| BIOSERV Diagnostics | 01-Jan-2012 | Buyout/LBO | Diagnostic Equipment | ||
| humatrix | 25-Nov-2011 | Buyout/LBO | Biotechnology |
R-Biopharm Exits (1)
R-Biopharm’s most recent exit was on 18-May-2010 from Zedira. The exit was categorized as with 2 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Zedira | 18-May-2010 | Completed |
|
R-Biopharm Affiliates
Subsidiaries (17)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Aprimeo Diagnostics | Pfungstadt, Germany | 2019 | |
| R-Biopharm Nederland | Arnhem, Netherlands | 2018 | |
| Wolfgang Mock | Gross-Umstadt, Germany | 2014 | |
| CoGAP | Koln, Germany | 2010 | |
| BIOAVID Diagnostics | Darmstadt, Germany | 2008 |
R-Biopharm FAQs
-
When was R-Biopharm founded?
R-Biopharm was founded in 1988.
-
Where is R-Biopharm headquartered?
R-Biopharm is headquartered in Darmstadt, Germany.
-
What is the size of R-Biopharm?
R-Biopharm has 1,400 total employees.
-
What industry is R-Biopharm in?
R-Biopharm’s primary industry is Biotechnology.
-
Is R-Biopharm a private or public company?
R-Biopharm is a Private company.
-
What is R-Biopharm’s current revenue?
The current revenue for R-Biopharm is .
-
Who are R-Biopharm’s investors?
Federal State of Hesse has invested in R-Biopharm.
-
Who are R-Biopharm’s competitors?
VMRD, Astra Biotech, Enzo Biochem, Organogenesis Holdings, and Meridian Bioscience are some of the 17 competitors of R-Biopharm.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process